Legal Representation
Attorney
Mary Anthony Merchant, Ph.D.
USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 15, 2002 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 18, 2001 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 28, 2001 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 18, 2001 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 21, 2001 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Dec 7, 2000 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 23, 2000 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 14, 2000 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 22, 2000 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 20, 1999 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 26, 1999 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 23, 1999 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 29, 1998 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 27, 1998 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 7, 1998 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 1, 1998 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Sep 24, 1998 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005